000			03758nam a2200409 i 4500
999			_c396591 _d396591
001			396591
003			ES-MaUEC
005			20230718102234.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			220203s2022 xxua o |||| 0|eng d
020			_a9781071621684
024	7		_a10.1007/978-1-0716-2168-4 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aSF915 _b2022 EB
245	0	0	_aVaccine Technologies for Veterinary Viral Diseases : _bMethods and Protocols _cedited by Alejandro Brun
250			_a2nd edition 2022
264		1	_aNew York, NY _bSpringer International Publising _c2022
300			_a1 recurso en línea (XI, 306 páginas) _b54 ilustraciones, 43 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Molecular Biology _x1940-6029 _v2465
505	0		_aAn overview of veterinary viral diseases and vaccine technologies -- Production and purification of candidate subunit vaccines by IC-tagging protein encapsulation -- Elastin‐like polymers as nanovaccines: protein engineering of self‐assembled, epitope-exposing nanoparticles -- Display of heterologous proteins in Bacillus subtilis biofilms for enteric immunization -- Production of influenza H5 vaccine oligomers in plants -- DNA vaccines in pigs: from immunization to antigen identification -- Use of foot-and-mouth disease virus non-coding synthetic RNAs as vaccine adjuvants -- Evaluation of innate lymphoid cells and dendritic cells following viral vector vaccination -- Generation of replication deficient human adenovirus 5 (Ad5) vectored FMD vaccines -- Recombinant modified vaccinia virus Ankara development to express VP2, NS1, and VP7 proteins of Bluetongue virus -- Cloning strategies for the generation of recombinant capripoxvirus through the use of screening and selection markers -- Using Rift Valley fever virus as a vector platform for the expression of ruminant disease antigens -- Generation and characterization of single-cycle infectious canine Influenza A Virus (sciCIV) and its use as vaccine platform -- Reverse genetics for influenza A and B viruses driven by swine polymerase I promoter -- Analysis of the cellular immune responses to vaccines. .
520			_aThis second edition includes a collection of antigen production and delivery strategies for vaccine development in veterinary species. New and updated chapters guide readers through protocols for antigen production, experimental antigen delivery and the analysis of immune responses upon vaccination. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols. Authoritative and cutting-edge, Vaccine Technologies for Veterinary Viral Diseases: Methods and Protocols, Second Edition aims to be a useful and practical guide to researches to help further their study in this field. .
988			_aSpringer_Protocols_2022
650		7	_2embne _9141241 _aFarmacología veterinaria
650		7	_2embne _9146057 _aInmunología veterinaria
776	0	8	_iPrinted edition: _z9781071621677
776	0	8	_iPrinted edition: _z9781071621691
776	0	8	_iPrinted edition: _z9781071621707
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-2168-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b07/2023 _dz _eb _zSI